BRPI0918134A2 - derivado de prostaglandina i2 - Google Patents

derivado de prostaglandina i2

Info

Publication number: BRPI0918134A2
Authority: BR; Brazil
Prior art keywords: prostaglandin; derivative
Prior art date: 2008-09-10

Application number

BRPI0918134A

Other languages

English (en)

Inventor

Katsuhiko Konishi

Masahiro Amakawa

Shin Teradaira

Takahiko Murata

Yasushi Matsumura

Original Assignee

Asahi Glass Co Ltd

Kaken Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-09-10

Filing date

2009-09-08

Publication date

2016-03-01

2009-09-08 Application filed by Asahi Glass Co Ltd, Kaken Pharma Co Ltd filed Critical Asahi Glass Co Ltd

2016-03-01 Publication of BRPI0918134A2 publication Critical patent/BRPI0918134A2/pt

2019-02-12 Publication of BRPI0918134B1 publication Critical patent/BRPI0918134B1/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

BRPI0918134-2A 2008-09-10 2009-09-08 Derivado de prostaglandina i2 BRPI0918134B1 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
JP2008-232133		2008-09-10
JP2008232133		2008-09-10
JP2009168193		2009-07-16
JP2009-168193		2009-07-16
PCT/JP2009/065690 WO2010029925A1 (ja)	2008-09-10	2009-09-08	新規なプロスタグランジンｉ２誘導体

Publications (2)

Publication Number	Publication Date
BRPI0918134A2 true BRPI0918134A2 (pt)	2016-03-01
BRPI0918134B1 BRPI0918134B1 (pt)	2019-02-12

Family

ID=42005178

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0918134-2A BRPI0918134B1 (pt)	2008-09-10	2009-09-08	Derivado de prostaglandina i2

Country Status (15)

Country	Link
US (4)	US8394844B2 (pt)
EP (1)	EP2343292B1 (pt)
JP (1)	JP5468007B2 (pt)
KR (1)	KR101645752B1 (pt)
CN (1)	CN102209719B (pt)
AU (1)	AU2009292555B2 (pt)
BR (1)	BRPI0918134B1 (pt)
CA (1)	CA2736039C (pt)
DK (1)	DK2343292T3 (pt)
ES (1)	ES2522971T3 (pt)
MX (1)	MX2011002573A (pt)
PL (1)	PL2343292T3 (pt)
PT (1)	PT2343292E (pt)
RU (1)	RU2509768C2 (pt)
WO (1)	WO2010029925A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK2343292T3 (da)	2008-09-10	2014-11-03	Asahi Glass Co Ltd	Nyt prostaglandin 12-derivat
LT2447254T (lt)	2009-06-26	2018-01-10	Nippon Shinyaku Co., Ltd.	Kristalai
CN102917703B (zh) *	2010-03-08	2015-08-19	科研制药株式会社	新型ep4激动剂
JP6219277B2 (ja) *	2011-07-08	2017-10-25	ディフェンシンセラピューティクスアンパルトセルスカブＤｅｆｅｎｓｉｎＴｈｅｒａｐｅｕｔｉｃｓＡｐｓ	炎症性腸疾患の経口治療
ES2767583T3 (es) *	2012-10-26	2020-06-18	Agc Inc	Método para fabricar un compuesto de difluorolactona
AU2014305843B2 (en)	2013-08-09	2019-08-29	Ardelyx, Inc.	Compounds and methods for inhibiting phosphate transport
WO2016168090A1 (en) *	2015-04-14	2016-10-20	Nueon, Inc.	Method and apparatus for determining markers of health by analysis of blood
EP4706758A3 (en)	2019-05-21	2026-05-06	Ardelyx, Inc.	Methods for inhibiting phosphate transport
CN114341098B (zh) *	2019-10-11	2024-03-12	国立大学法人东北大学	环戊烷化合物的制备方法、内酯化合物的制备方法、二醇化合物的制备方法和化合物
HU231350B1 (hu) *	2019-12-18	2023-01-28	CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt	Eljárás királis prosztaglandin-enol intermedier előállítására, és az eljárásban hasznos köztitermék vegyületek
TW202400150A (zh)	2022-05-16	2024-01-01	日商Ａｇｃ股份有限公司	IL-6及/或IL-1β抑制劑
GB202211232D0 (en)	2022-08-02	2022-09-14	Heptares Therapeutics Ltd	Prostaglandin EP4 receptor agonist compounds

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE788209A (fr)	1971-09-01	1973-02-28	Pfizer	Derives tetrazoyliques des prostaglandines naturelles
NL7401493A (pt)	1973-02-08	1974-08-12
US4705806A (en) *	1978-02-13	1987-11-10	Morton Jr Douglas R	Prostacyclin analogs
US4565827A (en) *	1980-10-27	1986-01-21	Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T.	7-Substituted PGI2 -derivatives and pharmaceutical compositions containing them
JPH0655730B2 (ja) *	1987-07-17	1994-07-27	ザヌトラスウィートカンパニー	強力甘味剤
WO1990000552A1 (en) *	1988-07-12	1990-01-25	The Nutrasweet Company	High potency sweetening agents
US4881288A (en) *	1988-07-13	1989-11-21	Tennant Trend Inc.	Center feed dispenser for cleaning solution
JP2500371B2 (ja)	1993-11-08	1996-05-29	工業技術院長	半導体薄膜の成長方法
DE69531110T2 (de) *	1994-02-17	2004-05-19	Asahi Glass Co., Ltd.	Difluoroprostacycline, Zwischenprodukte zu deren Herstellung und Herstellungsverfahren
JP3719524B2 (ja)	1994-03-17	2005-11-24	旭硝子株式会社	ジハロゲン化プロスタサイクリン類の製造方法
JP3769738B2 (ja)	1994-04-11	2006-04-26	旭硝子株式会社	ジフルオロプロスタサイクリン類
JPH08217772A (ja)	1995-02-13	1996-08-27	Asahi Glass Co Ltd	ジフルオロ置換ビニルエーテル類の製造方法
TW401408B (en)	1995-07-21	2000-08-11	Fujisawa Pharmaceutical Co	Heterocyclic compounds having prostaglandin I2 agonism
JP3598611B2 (ja)	1995-10-17	2004-12-08	旭硝子株式会社	ジフルオロ化合物の製造方法
AU717104B2 (en)	1995-11-14	2000-03-16	Toray Industries, Inc.	Ocular depressor
TW416953B (en)	1996-09-25	2001-01-01	Takeda Chemical Industries Ltd	Tricyclic compounds for eliciting a prostaglandin I2 receptor agonistic effect, their production and use
AUPO440696A0 (en)	1996-12-30	1997-01-23	Fujisawa Pharmaceutical Co., Ltd.	New use
US6340693B1 (en)	1997-03-14	2002-01-22	Toray Industries, Inc.	Protective agent for nervous system structural cells
IT1299191B1 (it)	1998-06-23	2000-02-29	Sigma Tau Healthscience Spa	Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
CN1216050C (zh)	1998-10-23	2005-08-24	东丽株式会社	5,6,7－三去甲－4,8－内－间亚苯基pgi2衍生物及含有其的医药
ES2254726T3 (es) *	2001-07-16	2006-06-16	F. Hoffmann-La Roche Ag	Analogos de prostaglandina como agonistas receptores de ep4.
AU2003211574A1 (en)	2002-03-05	2003-09-16	Ono Pharmaceutical Co., Ltd.	8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
JP2005534653A (ja)	2002-06-06	2005-11-17	メルクフロストカナダアンドカンパニー	眼及び骨疾患の治療に於いてｅｐ４受容体作動薬として使用するための１，５−二置換イミダゾリジン−２−オン誘導体
JP5007169B2 (ja)	2007-02-20	2012-08-22	カルソニックカンセイ株式会社	電動コンプレッサ
EP1988087A1 (en)	2007-03-28	2008-11-05	Bayer Schering Pharma Aktiengesellschaft	Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of autoimmune diseases
JP2009168193A (ja)	2008-01-18	2009-07-30	Nachi Fujikoshi Corp	遊星歯車減速機
DK2343292T3 (da)	2008-09-10	2014-11-03	Asahi Glass Co Ltd	Nyt prostaglandin 12-derivat

2009
- 2009-09-08 DK DK09813071.9T patent/DK2343292T3/da active
- 2009-09-08 ES ES09813071.9T patent/ES2522971T3/es active Active
- 2009-09-08 WO PCT/JP2009/065690 patent/WO2010029925A1/ja not_active Ceased
- 2009-09-08 MX MX2011002573A patent/MX2011002573A/es active IP Right Grant
- 2009-09-08 PT PT98130719T patent/PT2343292E/pt unknown
- 2009-09-08 AU AU2009292555A patent/AU2009292555B2/en not_active Ceased
- 2009-09-08 CA CA2736039A patent/CA2736039C/en active Active
- 2009-09-08 BR BRPI0918134-2A patent/BRPI0918134B1/pt active IP Right Grant
- 2009-09-08 KR KR1020117007958A patent/KR101645752B1/ko active Active
- 2009-09-08 CN CN200980144732.5A patent/CN102209719B/zh active Active
- 2009-09-08 PL PL09813071T patent/PL2343292T3/pl unknown
- 2009-09-08 JP JP2010528724A patent/JP5468007B2/ja active Active
- 2009-09-08 EP EP09813071.9A patent/EP2343292B1/en active Active
- 2009-09-08 RU RU2011113967/04A patent/RU2509768C2/ru active
2010
- 2010-11-02 US US12/917,935 patent/US8394844B2/en active Active
2012
- 2012-11-13 US US13/675,530 patent/US8691857B2/en active Active
2014
- 2014-01-09 US US14/151,479 patent/US8877787B2/en active Active
- 2014-09-26 US US14/498,429 patent/US9034906B2/en active Active

Also Published As

Publication number	Publication date
CA2736039C (en)	2016-06-07
BRPI0918134B1 (pt)	2019-02-12
EP2343292A1 (en)	2011-07-13
KR101645752B1 (ko)	2016-08-04
JP5468007B2 (ja)	2014-04-09
US9034906B2 (en)	2015-05-19
CN102209719B (zh)	2014-05-14
US20110098481A1 (en)	2011-04-28
PL2343292T3 (pl)	2015-01-30
US20150018401A1 (en)	2015-01-15
US20130072530A1 (en)	2013-03-21
JPWO2010029925A1 (ja)	2012-02-02
MX2011002573A (es)	2011-07-28
WO2010029925A1 (ja)	2010-03-18
US8877787B2 (en)	2014-11-04
AU2009292555B2 (en)	2014-05-29
EP2343292A4 (en)	2012-03-21
EP2343292B1 (en)	2014-08-06
US8691857B2 (en)	2014-04-08
CA2736039A1 (en)	2010-03-18
RU2509768C2 (ru)	2014-03-20
PT2343292E (pt)	2014-11-04
DK2343292T3 (da)	2014-11-03
US20140128441A1 (en)	2014-05-08
RU2011113967A (ru)	2012-10-27
AU2009292555A1 (en)	2010-03-18
US8394844B2 (en)	2013-03-12
CN102209719A (zh)	2011-10-05
KR20110051286A (ko)	2011-05-17
ES2522971T3 (es)	2014-11-19

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
2018-04-24	B07E	Notice of approval relating to section 229 industrial property law
2018-09-04	B07A	Technical examination (opinion): publication of technical examination (opinion)
2018-11-21	B25D	Requested change of name of applicant approved	Owner name: KAKEN PHARMACEUTICAL CO., LTD (JP) ; AGC INC. (JP)
2019-01-02	B09A	Decision: intention to grant
2019-02-12	B16A	Patent or certificate of addition of invention granted	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/09/2009, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/09/2009, OBSERVADAS AS CONDICOES LEGAIS
2020-11-03	B25A	Requested transfer of rights approved	Owner name: AGC INC. (JP)
2020-11-24	B25G	Requested change of headquarter approved	Owner name: AGC INC. (JP)

Publication	Publication Date	Title
EP2376493A4 (en)	2012-05-30	DIHYDROPYRIMIDOPYRIMIDINDERIVAT
EP2380877A4 (en)	2012-06-27	PYRIDINE-3-CARBONSÄUREAMIDDERIVAT
EP2336132A4 (en)	2012-03-21	MORPHOLINPURINDERIVAT
DK2308877T3 (da)	2014-04-22	Imidazopyridin-2-on-derivater
EP2433940A4 (en)	2012-10-10	SPIROIMIDAZOLONDERIVAT
DK2340021T3 (da)	2012-12-10	Substituerede pyrrolidin-2-carboxamider
BRPI0915064A2 (pt)	2015-10-27	derivados de qunoxalinadiona
EP2226315A4 (en)	2012-01-25	2-aminoquinazoline DERIVATIVE
DK2288375T3 (da)	2012-05-21	Pegylerede insulin-lispro-forbindelser
BRPI0920707A2 (pt)	2015-12-29	compostos
DK2242759T3 (da)	2012-12-17	Forbindelser
BRPI0913832A2 (pt)	2015-10-20	derivados de pirrolopiridinilpirimidin-2-ilamina
EP2397480A4 (en)	2012-07-25	DIAZEPINEDIONEDERIVATE
BRPI0918134A2 (pt)	2016-03-01	derivado de prostaglandina i2
EP2344471A4 (en)	2012-05-30	7-PIPERIDINALKYL-3,4-dihydroquinolone DERIVATIVE
DK2323972T3 (da)	2013-10-07	C7-fluor-substituerede tetracylinforbindelser
DK2275414T3 (da)	2015-06-22	Cyclopentylacrylamidderivat
DK2297162T3 (da)	2012-11-26	Forbindelser
BRPI0906888A2 (pt)	2015-11-03	derivado de fenilacetamida
ATE545635T1 (de)	2012-03-15	Substituierte n-oxidpyrazinderivate
EP2495246A4 (en)	2013-06-26	FULLER DERIVATIVE
BRPI0922652A2 (pt)	2015-08-11	Derivados de quinazolinamida
BRPI0913234A2 (pt)	2016-01-19	derivados de tiazolilpiperidina
EP2401281A4 (en)	2012-08-15	PYRIMIDINPYRIMIDOINDAZOLDERIVAT
EP2457898A4 (en)	2012-12-19	FULLER DERIVATIVE